EN PL
COVID-19/SARS-COV-2 / EDITORIAL ARTICLE
COVID-19 – rheumatic diseases and rheumatologists
 
More details
Hide details
1
Early Arthritis Clinic, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland
 
 
Online publication date: 2021-07-11
 
 
Reumatologia 2021;59(3):129-131
 
ABSTRACT
After battling – for more than a year – the SARS-CoV-2 pandemic and its successive waves affecting different regions of the world, the medical community, regardless of the specialization its members represent, has achieved a basic understanding of the main problems this virus poses. The knowledge gained throughout the pandemic concerns a wide range of issues – from the course of the disease, which is often unpredictable, through the methods of therapeutic treatment, to the emergence of the post-COVID phenomena. Since the emergence of the pandemic one of the fundamental problems encountered by the medical community has been the identification of factors that negatively influence the outcome of the infection and those that seem beneficial for the patients.
 
REFERENCES (10)
1.
Fisayo T, Tsukagoshi S. Three waves of the COVID-19 pandemic. Postgrad Med J 2021; 97: 332, DOI: 10.1136/postgradmedj-2020-138564.
 
2.
Gianfrancesco MA, Leykina LA, Izadi Z, et al. Association of race and ethnicity with COVID-19 outcomes in rheumatic disease: data from the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis Rheumatol 2021; 73: 374–380, DOI: 10.1002/art.41567.
 
3.
Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol 2021; 17: 71–72, DOI: 10.1038/s41584-020-00562-2.
 
4.
Strangfeld A, Schäfer M, Gianfrancesco MA, COVID-19 Glo­bal Rheumatology Alliance, et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 2021; 80: 930–942, DOI: 10.1136/annrheumdis-2020-219498.
 
5.
Wang J, Saguner AM, An J, et al. Dysfunctional coagulation in COVID-19: from cell to bedside. Adv Ther 2020; 7: 3033–3039, DOI: 10.1007/s12325-020-01399-7.
 
6.
Griffin CL, Sharma V, Sarfati MR, et al. Aortic disease in the time of COVID-19 and repercussions on patient care at an academic aortic center. J Vasc Surg 2020; 72: 408–413, DOI: 10.1016/j.jvs.2020.04.487.
 
7.
Cañas CA. The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med Hypotheses 2020; 145: 110345, DOI: 10.1016/j.mehy.2020.110345.
 
8.
Salamanna F, Veronesi F, Martini L, et al. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne) 2021; 8: 653516, DOI: 10.3389/fmed.2021.653516.
 
9.
Wu W, Zhang Y, Wang P, et al. Psychological stress of medical staffs during outbreak of COVID-19 and adjustment strategy. J Med Virol 2020; 92: 1962–1970, DOI: 10.1002/jmv.25914.
 
10.
Lima CKT, Carvalho PMM, Lima IAAS, et al. The emotional impact of coronavirus 2019-Ncov (new coronavirus disease). Psychiatry Res 2020; 287: 112915, DOI: 10.1016/j.psychres. 2020.112915.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top